US6620406B1
(en)
|
1994-03-08 |
2003-09-16 |
Genetics Institute, Llc. |
Methods for treatment of periodontal diseases and lesions using bone morphogenetic proteins
|
US5626861A
(en)
*
|
1994-04-01 |
1997-05-06 |
Massachusetts Institute Of Technology |
Polymeric-hydroxyapatite bone composite
|
US6369116B1
(en)
|
1995-06-02 |
2002-04-09 |
Oculex Pharmaceuticals, Inc. |
Composition and method for treating glaucoma
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
US5674292A
(en)
|
1995-06-07 |
1997-10-07 |
Stryker Corporation |
Terminally sterilized osteogenic devices and preparation thereof
|
IL125552A0
(en)
*
|
1996-02-09 |
1999-03-12 |
Amgen Inc |
Composition comprising interleukin-1 inhibitor and controlled release polymer
|
EP0852951A1
(de)
|
1996-11-19 |
1998-07-15 |
Roche Diagnostics GmbH |
Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
|
ZA9711580B
(en)
*
|
1996-12-25 |
1999-09-23 |
Hoechst Marion Roussel Ltd |
Process for the production of purified dimeric bone morphogenetic factors.
|
WO1998034655A1
(en)
*
|
1997-02-07 |
1998-08-13 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
AU779278B2
(en)
*
|
1997-02-07 |
2005-01-13 |
Stryker Corporation |
Matrix-free osteogenic devices, implants and methods of use thereof
|
US7041641B2
(en)
|
1997-03-20 |
2006-05-09 |
Stryker Corporation |
Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
|
US20010016646A1
(en)
|
1998-03-20 |
2001-08-23 |
David C. Rueger |
Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
|
US6071982A
(en)
*
|
1997-04-18 |
2000-06-06 |
Cambridge Scientific, Inc. |
Bioerodible polymeric semi-interpenetrating network alloys for surgical plates and bone cements, and method for making same
|
AU7260598A
(en)
*
|
1997-04-28 |
1998-11-24 |
Trustees Of The University Of Pennsylvania, The |
Method for promoting myogenesis using osteogenic proteins
|
US6391336B1
(en)
*
|
1997-09-22 |
2002-05-21 |
Royer Biomedical, Inc. |
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
US7964192B1
(en)
*
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
US7790856B2
(en)
*
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
US20050059802A1
(en)
*
|
1998-04-07 |
2005-03-17 |
Neuralab Ltd |
Prevention and treatment of amyloidogenic disease
|
AU772479B2
(en)
*
|
1998-10-06 |
2004-04-29 |
Stryker Corporation |
Repair of larynx, trachea, and other fibrocartilaginous tissues
|
DE19906096A1
(de)
|
1999-02-13 |
2000-08-17 |
Walter Sebald |
Protein mit einem Heparin-bindenden Epitop
|
US7371408B1
(en)
*
|
1999-06-07 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US20090060988A1
(en)
*
|
1999-10-05 |
2009-03-05 |
Kang Ting |
Nell-1 enhanced bone mineralization
|
US7884066B2
(en)
*
|
1999-10-05 |
2011-02-08 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
US7052856B2
(en)
*
|
1999-10-05 |
2006-05-30 |
The Regents Of The University Of California |
NELL-1 enhanced bone mineralization
|
WO2004024893A2
(en)
*
|
2002-09-13 |
2004-03-25 |
The Regents Of The University Of California |
Nell-1 enhanced bone mineralization
|
US7687462B2
(en)
*
|
1999-10-05 |
2010-03-30 |
The Regents Of The University Of California |
Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
|
EP1155704A1
(de)
*
|
2000-01-13 |
2001-11-21 |
Chih-I Lin |
Orthopädisches Füllmaterial und Verfahren zu dessen Verwendung
|
US6630153B2
(en)
*
|
2001-02-23 |
2003-10-07 |
Smith & Nephew, Inc. |
Manufacture of bone graft substitutes
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
SE517168C2
(sv)
*
|
2000-07-17 |
2002-04-23 |
Bone Support Ab |
En komposition för ett injicerbart ersättningsmaterial för benmineral
|
US20080233165A1
(en)
*
|
2000-08-07 |
2008-09-25 |
Biolok International, Inc. |
Time release calcium sulfate and growth factor matrix for bone augmentation
|
US6699493B2
(en)
|
2000-11-29 |
2004-03-02 |
Oculex Pharmaceuticals, Inc. |
Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
|
PE20020574A1
(es)
*
|
2000-12-06 |
2002-07-02 |
Wyeth Corp |
Anticuerpos humanizados que reconocen el peptido amiloideo beta
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
US6949251B2
(en)
*
|
2001-03-02 |
2005-09-27 |
Stryker Corporation |
Porous β-tricalcium phosphate granules for regeneration of bone tissue
|
WO2002083188A2
(en)
*
|
2001-04-16 |
2002-10-24 |
Cassidy James J |
Dense/porous structures for use as bone substitutes
|
US20050129732A1
(en)
*
|
2001-07-13 |
2005-06-16 |
Flow Focusing, Inc. |
Biodegradable, antibiotic, controlled release tape
|
US20060263401A1
(en)
*
|
2001-07-13 |
2006-11-23 |
Flow Focusing, Inc. |
Formulation and Method for Preventing Infection
|
US20070254009A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic/bone morphogenic protein formulation and method of treatment
|
US20070254008A1
(en)
*
|
2001-07-13 |
2007-11-01 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US7371409B2
(en)
*
|
2001-09-06 |
2008-05-13 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
SI1448246T2
(sl)
*
|
2001-11-19 |
2015-12-31 |
Scil Technology Gmbh |
Postopek za proizvodnjo homogeno obložene naprave, ki ima osteoinduktivne in osteokonduktivne lastnosti
|
CA2474919A1
(en)
*
|
2002-02-08 |
2003-08-14 |
Wyeth |
Formulation comprising bioactive agents and method of using same
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
EP1489998B1
(de)
*
|
2002-03-29 |
2010-12-08 |
Wright Medical Technology, Inc. |
Knochentransplantat-ersatzzusammensetzung
|
US7291179B2
(en)
*
|
2002-06-24 |
2007-11-06 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US6652887B1
(en)
|
2002-06-24 |
2003-11-25 |
Wright Medical Technology, Inc. |
Bone graft substitute composition
|
US20040002770A1
(en)
*
|
2002-06-28 |
2004-01-01 |
King Richard S. |
Polymer-bioceramic composite for orthopaedic applications and method of manufacture thereof
|
US20040023322A1
(en)
*
|
2002-08-01 |
2004-02-05 |
Goodheart Clyde R. |
Method of producing non-recombinant BMP-2 and use thereof
|
US7029006B2
(en)
*
|
2002-08-29 |
2006-04-18 |
Canon Kabushiki Kaisha |
Sheet feeding apparatus and image forming apparatus
|
US8986737B2
(en)
*
|
2002-09-05 |
2015-03-24 |
Wm. Marsh Rice University |
Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth
|
AU2003253049A1
(en)
*
|
2002-09-10 |
2004-04-30 |
Scil Technology Gmbh |
Metal implant coated under reduced oxygen concentration with osteoinductive protein
|
US7164005B2
(en)
*
|
2002-10-17 |
2007-01-16 |
Alkermes, Inc. |
Microencapsulation and sustained release of biologically active polypeptides
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
BRPI0407058A
(pt)
*
|
2003-02-01 |
2006-01-17 |
Neuralab Ltd |
Métodos de profilaxia e de tratamento de uma doença, composição farmacêutica, e, uso de um fragmento
|
US7507257B2
(en)
*
|
2003-02-04 |
2009-03-24 |
Wright Medical Technology, Inc. |
Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects
|
ATE504649T1
(de)
*
|
2003-02-07 |
2011-04-15 |
Univ California |
Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids
|
TWI306458B
(en)
*
|
2003-05-30 |
2009-02-21 |
Elan Pharma Int Ltd |
Humanized antibodies that recognize beta amyloid peptide
|
AU2004249213A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
US20040262809A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Smith Todd S. |
Crosslinked polymeric composite for orthopaedic implants
|
WO2005037232A2
(en)
|
2003-10-17 |
2005-04-28 |
Joslin Diabetes Center, Inc. |
Methods and compositions for modulating adipocyte function
|
US20070224278A1
(en)
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20050250737A1
(en)
*
|
2003-11-12 |
2005-11-10 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US8734525B2
(en)
*
|
2003-12-31 |
2014-05-27 |
Warsaw Orthopedic, Inc. |
Osteoinductive demineralized cancellous bone
|
US20070231788A1
(en)
*
|
2003-12-31 |
2007-10-04 |
Keyvan Behnam |
Method for In Vitro Assay of Demineralized Bone Matrix
|
US8328876B2
(en)
*
|
2003-12-31 |
2012-12-11 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
BRPI0506983A
(pt)
|
2004-01-20 |
2007-07-03 |
Allergan Inc |
composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
|
US8377904B2
(en)
*
|
2004-02-09 |
2013-02-19 |
Hill's Pet Nutrition, Inc. |
Composition and method for use in cartilage affecting conditions
|
US7691607B2
(en)
*
|
2004-02-09 |
2010-04-06 |
The Regents Of The University Of California |
Expression system of NELL peptide
|
US7456254B2
(en)
*
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
EP2409707B8
(de)
|
2004-04-15 |
2015-05-06 |
Alkermes Pharma Ireland Limited |
Vorrichtung auf Polymerbasis mit verzögerter Freisetzung
|
US8455656B2
(en)
|
2004-04-30 |
2013-06-04 |
Allergan, Inc. |
Kinase inhibitors
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US20050244469A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
US20050244458A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular neuropathies
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US20050244461A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Controlled release drug delivery systems and methods for treatment of an eye
|
US20050244462A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Devices and methods for treating a mammalian eye
|
US8722097B2
(en)
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
US20050244471A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Estradiol derivative and estratopone containing sustained release intraocular implants and related methods
|
US8119154B2
(en)
*
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050244466A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Photodynamic therapy in conjunction with intraocular implants
|
US8425929B2
(en)
*
|
2004-04-30 |
2013-04-23 |
Allergan, Inc. |
Sustained release intraocular implants and methods for preventing retinal dysfunction
|
US20070059336A1
(en)
*
|
2004-04-30 |
2007-03-15 |
Allergan, Inc. |
Anti-angiogenic sustained release intraocular implants and related methods
|
US20050244478A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Anti-excititoxic sustained release intraocular implants and related methods
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US20050244465A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Drug delivery systems and methods for treatment of an eye
|
US20050244463A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Sustained release intraocular implants and methods for treating ocular vasculopathies
|
US8512738B2
(en)
|
2004-04-30 |
2013-08-20 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase implants
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US7384430B2
(en)
*
|
2004-06-30 |
2008-06-10 |
Depuy Products, Inc. |
Low crystalline polymeric material for orthopaedic implants and an associated method
|
EP2216026B1
(de)
*
|
2004-07-12 |
2016-04-20 |
Allergan, Inc. |
Ophthalmologische Zusammensetzungen und deren Verwendung zur Behandlung von Augenkrankheiten
|
CA2579962A1
(en)
*
|
2004-08-09 |
2006-06-01 |
Enrique Melendez Hevia |
Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders
|
US7250550B2
(en)
*
|
2004-10-22 |
2007-07-31 |
Wright Medical Technology, Inc. |
Synthetic bone substitute material
|
WO2006066171A1
(en)
*
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Amyloid βετα antibodies for use in improving cognition
|
EP1838854B1
(de)
*
|
2004-12-15 |
2012-10-31 |
Janssen Alzheimer Immunotherapy |
Antikörper, die Amyloid-Peptide erkennen
|
CA2590337C
(en)
*
|
2004-12-15 |
2017-07-11 |
Neuralab Limited |
Humanized amyloid beta antibodies for use in improving cognition
|
US7883653B2
(en)
|
2004-12-30 |
2011-02-08 |
Depuy Products, Inc. |
Method of making an implantable orthopaedic bearing
|
US7896921B2
(en)
*
|
2004-12-30 |
2011-03-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
US7879275B2
(en)
*
|
2004-12-30 |
2011-02-01 |
Depuy Products, Inc. |
Orthopaedic bearing and method for making the same
|
MX2007009091A
(es)
*
|
2005-01-28 |
2008-01-11 |
Wyeth Corp |
Formulaciones de polipeptido liquidas estabilizadas.
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
KR20070121669A
(ko)
|
2005-02-16 |
2007-12-27 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
뼈 상태 치료 또는 예방을 위한 약제학적 조성물
|
CA2602419A1
(fr)
*
|
2005-02-24 |
2006-08-31 |
Roland Dricot |
Implant osseux
|
US20100150885A1
(en)
|
2005-06-01 |
2010-06-17 |
Joslin Diabetes Center, Inc. |
Methods and compositions for inducing brown adipogenesis
|
US20060286171A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Tianhong Zhou |
Bone morphogenetic protein formulations
|
DK1933892T3
(da)
|
2005-09-09 |
2013-03-25 |
Agnovos Healthcare Llc |
Sammensat knoglegrafterstatningscement og artikler fremstillet deraf
|
US8025903B2
(en)
*
|
2005-09-09 |
2011-09-27 |
Wright Medical Technology, Inc. |
Composite bone graft substitute cement and articles produced therefrom
|
US8911759B2
(en)
*
|
2005-11-01 |
2014-12-16 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
WO2007136664A2
(en)
*
|
2006-05-16 |
2007-11-29 |
Flow Focusing, Inc. |
Antibiotic formulation and method of treatment
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8197840B2
(en)
*
|
2006-07-21 |
2012-06-12 |
Genera Istrazivanja D.O.O. |
Whole blood-derived coagulum device for treating bone defects
|
US8101198B2
(en)
*
|
2006-07-26 |
2012-01-24 |
The Regents Of The University Of California |
Osteogenic enhancer composition
|
US20080051796A1
(en)
*
|
2006-08-01 |
2008-02-28 |
Warsaw Orthopedic, Inc. |
Graft retention tack
|
AU2007284759B2
(en)
|
2006-08-09 |
2010-10-28 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
US8969415B2
(en)
|
2006-12-01 |
2015-03-03 |
Allergan, Inc. |
Intraocular drug delivery systems
|
AU2007234612B2
(en)
*
|
2006-12-14 |
2013-06-27 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein stabilization formulations
|
DE102006060958A1
(de)
*
|
2006-12-20 |
2008-06-26 |
Jennissen, Herbert P., Prof. Dr. |
Verfahren zur Herstellung einer Polymermatrix, daraus bestehende Implantate sowie deren Verwendung
|
US20080233199A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Alkermes, Inc. |
Coacervation Process
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
CA2684323A1
(en)
*
|
2007-04-18 |
2008-10-30 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of cerebral amyloid angiopathy
|
US7911053B2
(en)
*
|
2007-04-19 |
2011-03-22 |
Marvell World Trade Ltd. |
Semiconductor packaging with internal wiring bus
|
AU2008244523B2
(en)
|
2007-04-23 |
2012-02-16 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
WO2008143867A1
(en)
*
|
2007-05-15 |
2008-11-27 |
Stryker Corporation |
Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
|
WO2008157497A2
(en)
*
|
2007-06-15 |
2008-12-24 |
Osteotech, Inc. |
Method of treating tissue
|
AU2008265850B2
(en)
*
|
2007-06-15 |
2014-06-26 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions and methods
|
US9554920B2
(en)
|
2007-06-15 |
2017-01-31 |
Warsaw Orthopedic, Inc. |
Bone matrix compositions having nanoscale textured surfaces
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
US20110054408A1
(en)
*
|
2007-07-10 |
2011-03-03 |
Guobao Wei |
Delivery systems, devices, tools, and methods of use
|
WO2009009688A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Osteotech, Inc. |
Delivery system
|
ES2498040T3
(es)
|
2007-07-27 |
2014-09-24 |
Janssen Alzheimer Immunotherapy |
Tratamiento de enfermedades amiloidogénicas con anticuerpos anti-beta humanizados
|
CN101801405A
(zh)
*
|
2007-08-07 |
2010-08-11 |
先进科技及再生医学有限责任公司 |
包含于酸性水溶液中的gdf-5的蛋白质配方
|
JO3076B1
(ar)
*
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
ES2446544T3
(es)
*
|
2007-10-19 |
2014-03-10 |
Warsaw Orthopedic, Inc. |
Composiciones de matrices óseas desmineralizadas y métodos
|
DE102007051914A1
(de)
*
|
2007-10-29 |
2009-05-07 |
Herbert Prof. Dr. Jennissen |
Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel
|
EP2240155B1
(de)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
|
AU2009236459B2
(en)
*
|
2008-04-14 |
2013-07-25 |
Advanced Technologies And Regenerative Medicine, Llc |
Liquid buffered GDF-5 formulations
|
US9616153B2
(en)
*
|
2008-04-17 |
2017-04-11 |
Warsaw Orthopedic, Inc. |
Rigid bone graft substitute
|
EP2283119B1
(de)
*
|
2008-05-06 |
2015-01-07 |
Joslin Diabetes Center, Inc. |
Verfahren und zusammensetzungen zur einleitung von brauner adipogenese
|
US9492375B2
(en)
*
|
2008-07-23 |
2016-11-15 |
Warsaw Orthopedic, Inc. |
Foam carrier for bone grafting
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
WO2010093955A1
(en)
*
|
2009-02-12 |
2010-08-19 |
Osteotech,Inc. |
Segmented delivery system
|
US9409963B2
(en)
|
2009-05-26 |
2016-08-09 |
The Regents Of The University Of California |
Fibromodulin peptide
|
RU2547990C2
(ru)
|
2009-09-28 |
2015-04-10 |
Интарсия Терапьютикс, Инк. |
Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства
|
KR20170095402A
(ko)
|
2009-11-09 |
2017-08-22 |
알러간, 인코포레이티드 |
모발 성장을 촉진하기 위한 조성물 및 방법
|
JP5669050B2
(ja)
*
|
2010-01-15 |
2015-02-12 |
国立大学法人島根大学 |
骨セメント
|
US9180137B2
(en)
|
2010-02-09 |
2015-11-10 |
Bone Support Ab |
Preparation of bone cement compositions
|
WO2011137231A1
(en)
*
|
2010-04-29 |
2011-11-03 |
Warsaw Orthopedic, Inc. |
Flowable ceramic putty
|
WO2011143226A1
(en)
|
2010-05-11 |
2011-11-17 |
Howmedica Osteonics Corp. |
Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods
|
US9301976B2
(en)
|
2010-08-19 |
2016-04-05 |
The Regents Of The University Of California |
Compositions comprising perivascular stem cells and nell-1 protein
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
US9675670B2
(en)
|
2011-04-11 |
2017-06-13 |
Induce Biologics Inc. |
System and method for multiphasic release of growth factors
|
US8765189B2
(en)
|
2011-05-13 |
2014-07-01 |
Howmedica Osteonic Corp. |
Organophosphorous and multivalent metal compound compositions and methods
|
RU2014145234A
(ru)
|
2012-04-11 |
2016-05-27 |
Индьюс Байолоджикс Инк. |
Система и способ для многофазного высвобождения факторов роста
|
CA2901280A1
(en)
|
2013-02-15 |
2014-08-21 |
Allergan, Inc. |
Sustained drug delivery implant
|
TR201807495T4
(tr)
|
2013-02-20 |
2018-06-21 |
Bone Support Ab |
Sertleştirilebilir kemik ikamesine yönelik geliştirilmiş katılaştırma.
|
TWI651103B
(zh)
|
2013-12-13 |
2019-02-21 |
萊特醫技股份有限公司 |
多相骨移植替代材料
|
CA2943256C
(en)
|
2014-03-20 |
2021-04-27 |
Stayble Therapeutics Ab |
A composition for use in the treatment of intervertebral disc-related pain
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016109555A1
(en)
*
|
2014-12-29 |
2016-07-07 |
Bioventus, Llc |
Systems and methods for improved delivery of osteoinductive molecules in bone repair
|
EP3302354B1
(de)
|
2015-06-03 |
2023-10-04 |
i2o Therapeutics, Inc. |
Systeme zum einsetzen eines implantats
|
KR20180079368A
(ko)
|
2015-10-30 |
2018-07-10 |
바이오벤터스 엘엘씨 |
골 복구에서 골유도 분자의 증진된 전달을 위한 매트릭스
|
RU2760007C2
(ru)
|
2016-05-16 |
2021-11-22 |
Интарсия Терапьютикс, Инк. |
Полипептиды, селективные к рецепторам глюкагона, и способы их применения
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
CA3026660A1
(en)
|
2016-06-10 |
2017-12-14 |
Bioventus, Llc |
Protein delivery with porous metallic structure
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
US11103618B2
(en)
|
2018-02-22 |
2021-08-31 |
Warsaw Orthopedic, Inc. |
Demineralized bone matrix having improved handling characteristics
|